|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 78.00 EUR | +0.13% |
|
-1.14% | +4.00% |
| 11-28 | Bernstein raises easyJet; JPM cuts Burberry | AN |
| 11-19 | Thermo Fisher Scientific Introduces Thermo Scientific?? Suretect?? Beverage Spoilage Multiplex Qpcr Assay | CI |
| Capitalization | 35.09B 40.82B 32.87B 30.64B 56.59B 3,674B 61.56B 385B 148B 1,735B 153B 150B 6,345B | P/E ratio 2025 * |
19.3x | P/E ratio 2026 * | 17.8x |
|---|---|---|---|---|---|
| Enterprise value | 45.02B 52.37B 42.17B 39.31B 72.6B 4,713B 78.97B 493B 190B 2,226B 197B 192B 8,139B | EV / Sales 2025 * |
2.14x | EV / Sales 2026 * | 2.07x |
| Free-Float |
44.61% | Yield 2025 * |
2.62% | Yield 2026 * | 2.83% |
Last Transcript: Coca-Cola Europacific Partners plc
| 1 day | +0.13% | ||
| 1 week | -1.14% | ||
| Current month | -1.14% | ||
| 1 month | +2.36% | ||
| 3 months | +3.45% | ||
| 6 months | -4.29% | ||
| Current year | +4.00% |
| 1 week | 77.7 |  | 80.1 |
| 1 month | 77 | | 81.2 |
| Current year | 71.9 | | 87 |
| 1 year | 71.5 | | 87 |
| 3 years | 49.62 | | 87 |
| 5 years | 36.85 | | 87 |
| 10 years | 26.7 | | 87 |
| Manager | Title | Age | Since |
|---|---|---|---|
Damian Gammell
CEO | Chief Executive Officer | 54 | 27/12/2016 |
| Director of Finance/CFO | 58 | 30/06/2024 | |
Peter Brickley
CTO | Chief Tech/Sci/R&D Officer | - | 31/10/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 59 | 23/05/2016 | |
| Director/Board Member | 73 | 27/05/2016 | |
| Director/Board Member | 73 | 27/05/2016 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.13% | -1.14% | +5.69% | +56.69% | 40.82B | |
| -0.32% | -2.50% | -8.09% | -20.16% | 201B | |
| -0.79% | +3.20% | +10.59% | +32.55% | 19.02B | |
| -.--% | -.--% | - | - | 12.72B | |
| -0.92% | -2.55% | +15.53% | +95.58% | 3.03B | |
| 0.00% | 0.00% | -26.85% | -44.56% | 1.49B | |
| +0.32% | -2.31% | +0.48% | +20.76% | 937M | |
| -1.64% | -4.75% | +57.32% | +187.57% | 324M | |
| Average | -0.40% | -1.26% | +7.81% | +46.92% | 34.87B | |
| Weighted average by Cap. | -0.28% | -1.79% | -4.37% | -3.03% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 21B 24.43B 19.67B 18.33B 33.86B 2,198B 36.83B 230B 88.84B 1,038B 91.68B 89.72B 3,796B | 21.55B 25.07B 20.19B 18.81B 34.75B 2,256B 37.8B 236B 91.16B 1,065B 94.08B 92.07B 3,896B |
| Net income | 1.79B 2.09B 1.68B 1.57B 2.89B 188B 3.15B 19.66B 7.59B 88.71B 7.83B 7.67B 324B | 1.96B 2.28B 1.83B 1.71B 3.16B 205B 3.43B 21.45B 8.28B 96.81B 8.55B 8.37B 354B |
| Net Debt | 9.93B 11.55B 9.3B 8.67B 16.01B 1,039B 17.41B 109B 41.99B 491B 43.34B 42.41B 1,795B | 9.49B 11.04B 8.89B 8.29B 15.3B 994B 16.65B 104B 40.15B 469B 41.43B 40.55B 1,716B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/12/25 | 78.00 € | +0.13% | 20,032 |
| 04/12/25 | 77.90 € | -1.64% | 22,428 |
| 03/12/25 | 79.20 € | -0.25% | 7,966 |
| 02/12/25 | 79.40 € | +0.25% | 9,374 |
| 01/12/25 | 79.20 € | +0.38% | 7,636 |
Real-time Euronext Amsterdam, December 05, 2025 at 04:55 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CCEP Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition